MENU
+Compare
AVNS
Stock ticker: NYSE
AS OF
Dec 2 closing price
Price
$11.35
Change
-$0.23 (-1.99%)
Capitalization
537.53M

AVNS Avanos Medical Forecast, Technical & Fundamental Analysis

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally... Show more

AVNS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for AVNS with price predictions
Dec 01, 2025

Momentum Indicator for AVNS turns positive, indicating new upward trend

AVNS saw its Momentum Indicator move above the 0 level on December 01, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned positive. In of the 81 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for AVNS just turned positive on November 24, 2025. Looking at past instances where AVNS's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

AVNS moved above its 50-day moving average on November 24, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AVNS crossed bullishly above the 50-day moving average on December 01, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where AVNS advanced for three days, in of 278 cases, the price rose further within the following month. The odds of a continued upward trend are .

AVNS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 136 cases where AVNS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where AVNS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVNS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AVNS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.691) is normal, around the industry mean (63.233). P/E Ratio (33.106) is within average values for comparable stocks, (37.173). AVNS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.673). AVNS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (0.765) is also within normal values, averaging (35.612).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVNS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
AVNS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

AVNS is expected to report earnings to rise 13.64% to 25 cents per share on February 24

Avanos Medical AVNS Stock Earnings Reports
Q4'25
Est.
$0.25
Q3'25
Beat
by $0.04
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.08
Q4'24
Beat
by $0.03
The last earnings report on November 05 showed earnings per share of 21 cents, beating the estimate of 18 cents. With 519.11K shares outstanding, the current market capitalization sits at 537.53M.
A.I. Advisor
published General Information

General Information

a provider of health and healthcare products, which prevents infection, eliminating pain and speeding recovery

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
5405 Windward Parkway
Phone
+1 844 428-2667
Employees
3771
Web
https://www.avanos.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APHIX35.770.20
+0.56%
Artisan International Institutional
GLCGX35.54N/A
N/A
Goldman Sachs Large Cap Gr Insghts A
TLAFX12.89N/A
N/A
Transamerica Large Core ESG R4
PAHSX7.01N/A
N/A
PGIM Jennison NextGeneration Glb Opps A
RCMPX17.69-0.03
-0.17%
Lazard International Quality Gr R6

AVNS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AVNS has been loosely correlated with ENOV. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if AVNS jumps, then ENOV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVNS
1D Price
Change %
AVNS100%
-1.99%
ENOV - AVNS
51%
Loosely correlated
+0.07%
STE - AVNS
49%
Loosely correlated
-1.37%
CNMD - AVNS
49%
Loosely correlated
-1.06%
INSP - AVNS
45%
Loosely correlated
+6.01%
MDT - AVNS
45%
Loosely correlated
-1.27%
More

Groups containing AVNS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVNS
1D Price
Change %
AVNS100%
-1.99%
Medical/Nursing Services
industry (215 stocks)
49%
Loosely correlated
-0.65%
Health Services
industry (422 stocks)
1%
Poorly correlated
+0.00%